Editorial: The role of tumor microenvironment in primary liver cancer therapeutic resistance

被引：3
作者：
Pu, Zhangya [1 ]
Ren, Zhigang [2 ]
Xu, Qiuran [3 ,4 ]
Wang, Xiaochen [5 ]
Chen, Jian [6 ]
Chen, Jiang [7 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Infect Dis, Hangzhou, Peoples R China
[2] Zhengzhou Univ, Dept Infect Dis, Affiliated Hosp 1, Zhengzhou, Peoples R China
[3] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Lab Mol Diag, Hangzhou, Peoples R China
[4] Hangzhou Med Coll, Affiliated Peoples Hosp, Hangzhou, Peoples R China
[5] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA
[6] BioAtla Inc, Dept Res & Dev, San Diego, CA USA
[7] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gen Surg, Hangzhou, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词：
hepatocellular carcinoma; tumor microenvironment; immune infiltration; biomarkers; prognostic model; LACTATE;
D O I：
10.3389/fonc.2022.938557
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 11 条
[1]   Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells [J].
Dong, Qi ;
Zhou, Chenkang ;
Ren, Haodong ;
Zhang, Zhijian ;
Cheng, Feng ;
Xiong, Zhenkai ;
Chen, Chuantao ;
Yang, Jianke ;
Gao, Jiguang ;
Zhang, Yao ;
Xu, Lei ;
Fang, Jian ;
Cao, Yuxiang ;
Wei, Huijun ;
Wu, Zhihao .
CELL COMMUNICATION AND SIGNALING, 2020, 18 (01)
[2]   From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma [J].
Fu, Yaojie ;
Liu, Shanshan ;
Zeng, Shan ;
Shen, Hong .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (01)
[3]   LncRNA HOTAIR knockdown inhibits glycolysis by regulating miR-130a-3p/HIF1A in hepatocellular carcinoma under hypoxia [J].
Hu, Mingxing ;
Fu, Qiang ;
Jing, Chan ;
Zhang, Xu ;
Qin, Tao ;
Pan, Yanfeng .
BIOMEDICINE & PHARMACOTHERAPY, 2020, 125
[4]   Increased Visceral Adipose Tissue and Hyperinsulinemia Raise the Risk for Recurrence of Non-B Non-C Hepatocellular Carcinoma after Curative Treatment [J].
Imai, Kenji ;
Takai, Koji ;
Miwa, Takao ;
Maeda, Toshihide ;
Hanai, Tatsunori ;
Shiraki, Makoto ;
Suetsugu, Atsushi ;
Shimizu, Masahito .
CANCERS, 2021, 13 (07)
[5]   Potential therapeutics using tumor-secreted lactate in nonsmall cell lung cancer [J].
Liao, Zi-Xian ;
Kempson, Ivan M. ;
Hsieh, Chia-Chen ;
Tseng, S-Ja ;
Yang, Pan-Chyr .
DRUG DISCOVERY TODAY, 2021, 26 (11) :2508-2514
[6]   Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments [J].
Marasco, Giovanni ;
Serenari, Matteo ;
Renzulli, Matteo ;
Alemanni, Luigina Vanessa ;
Rossini, Benedetta ;
Pettinari, Irene ;
Dajti, Elton ;
Ravaioli, Federico ;
Golfieri, Rita ;
Cescon, Matteo ;
Festi, Davide ;
Colecchia, Antonio .
JOURNAL OF GASTROENTEROLOGY, 2020, 55 (10) :927-943
[7]   Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells [J].
Ruf, Benjamin ;
Heinrich, Bernd ;
Greten, Tim F. .
CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (01) :112-127
[8]   Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Sung, Hyuna ;
Ferlay, Jacques ;
Siegel, Rebecca L. ;
Laversanne, Mathieu ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin ;
Bray, Freddie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (03) :209-249
[9]   Hepatocellular Carcinoma [J].
Villanueva, Augusto .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (15) :1450-1462
[10]   Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17 [J].
Zhang, Anke ;
Xu, Yuanzhi ;
Xu, Houshi ;
Ren, Jie ;
Meng, Tong ;
Ni, Yunjia ;
Zhu, Qingwei ;
Zhang, Wen-Bo ;
Pan, Yuan-Bo ;
Jin, Jiali ;
Bi, Yunke ;
Wu, Zhe Bao ;
Lin, Shaojian ;
Lou, Meiqing .
THERANOSTICS, 2021, 11 (08) :3839-3852
12